Oral fluid-based biomarkers of alveolar bone loss in periodontitis

Annals of the New York Academy of Sciences

Volumn 1098, Issue , 2007, Pages 230-251

  Kinney, Janet S ^a   Ramseier, Christoph A ^a   Giannobile, William V ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Bone resorption; Diagnosis; Disease progression; Oral fluids; Periodontal disease; Saliva

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CALPROTECTIN; CATHEPSIN B; COLLAGEN TYPE 1; COLLAGENASE 3; GELATINASE; NEUTROPHIL COLLAGENASE; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; PYRIDINOLINE;

BONE TURNOVER; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; OSTEOLYSIS; PERIODONTITIS; CHEMISTRY; ENZYMOLOGY; JAW DISEASE; METABOLISM; MICROBIOLOGY; REVIEW; SALIVA;

ALVEOLAR BONE LOSS; BIOLOGICAL MARKERS; JAW DISEASES; PERIODONTITIS; SALIVA;

EID: 34248226871     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1384.028     Document Type: Conference Paper

References (129)

1. ARMITAGE, G.C. 1999. Development of a classification system for periodontal diseases and conditions. Ann. Periodontol. 4: 1-6.
2. SOCRANSKY, S.S. & A.D. HAFFAJEE. 1992. The bacterial etiology of destructive periodontal disease: current concepts. J. Periodontol. 63(4 Suppl): 322-331.
3. GENCO, R.J. 1992. Host responses in periodontal diseases: current concepts. J. Periodontol. 63(4 Suppl): 338-355.
4. PAGE, R.C. & K.S. KORNMAN. 1997. The pathogenesis of human periodontitis: an introduction. Periodontol. 2000 14: 9-11.
5. OFFENBACHER, S. 1996. Periodontal diseases: pathogenesis. Ann. Periodontol. 1: 821-878.
6. ALBANDAR, J.M. 1990. A 6-year study on the pattern of periodontal disease progression. J. Clin. Periodontol. 17(7 Pt 1): 467-471.
7. ALBANDAR, J.M. & D.K. ABBAS. 1986. Radiographic quantification of alveolar bone level changes. Comparison of 3 currently used methods. J. Clin. Periodontol. 13: 810-813.
8. SOCRANSKY, S.S., A.D. HAFFAJEE, J.M. GOODSON & J. LINDHE. 1984. New concepts of destructive periodontal disease. J. Clin. Periodontol. 11: 21-32.
9. ALBANDAR, J.M. 2002. Periodontal diseases in North America. Periodontol 2000. 29: 31-69.
10. ALBANDAR, J.M., J.A. BRUNELLE & A. KINGMAN. 1999. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994. J. Periodontol. 70: 13-29.
11. SOCRANSKY, S.S. & A.D. HAFFAJEE. 2002. Dental biofilms: difficult therapeutic targets. Periodontol. 2000. 28: 12-55.
12. ZAMBON, J.J. 1996. Periodontal diseases: microbial factors. Ann. Periodontol. 1: 879-925.
13. SOCRANSKY, S.S., A.D.HAFFAJEE, M.A. CUGINI, et al. 1998. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 25: 134-144.
14. LOESCHE, W.J., D.E. LOPATIN, J. GIORDANO, et al. 1992. Comparison of the benzoyl-DL-arginine-naphthylamide (BANA) test, DNA probes, and immunological reagents for ability to detect anaerobic periodontal infections due to Porphyromonas gingivalis, Treponema denticola, and Bacteroides forsythus. J. Clin. Microbiol. 30: 427-433.
15. LOESCHE, W.J., C.E. KAZOR & G.W. TAYLOR. 1997. The optimization of the BANA test as a screening instrument for gingivitis among subjects seeking dental treatment. J. Clin. Periodontol. 24: 718-726.
16. LISTGARTEN, M.A. 1976. Structure of surface coatings on teeth. A review. J. Periodontol. 47: 139-147.
17. LISTGARTEN, M.A. & P.M. LOOMER. 2003. Microbial identification in the management of periodontal diseases. A systematic review. Ann. Periodontol. 8: 182-192.
18. ARMITAGE, G.C. 1996. Periodontal diseases: diagnosis. Ann. Periodontol. 1: 37-215.
19. ARMITAGE, G.C. 2004. The complete periodontal examination. Periodontol. 2000 34: 22-33.
20. LAMSTER, I.B. & J.T. GRBIC. 1995. Diagnosis of periodontal disease based on analysis of the host response. Periodontol. 2000. 7: 83-99.
21. HAFFAJEE, A.D., S.S. SOCRANSKY & J.M. GOODSON. 1983. Clinical parameters as predictors of destructive periodontal disease activity. J. Clin. Periodontol. 10: 257-265.
22. GOODSON, J.M. 1992. Diagnosis of periodontitis by physical measurement: interpretation from episodic disease hypothesis. J. Periodontol. 63(4 Suppl): 373-382.
23. HAFFAJEE, A.D., S.S. SOCRANSKY, J. LINDHE, et al. Clinical risk indicators for periodontal attachment loss. J. Clin. Periodontol. 18: 117-125.
24. STRECKFUS, C.F. & L.R. BIGLER. 2002. Saliva as a diagnostic fluid. Oral Dis. 8: 69-76.
25. MANDEL, I.D. 1990. The diagnostic uses of saliva. J. Oral Pathol. Med. 19: 119-125.
26. MANDEL, I.D. 1993. Salivary diagnosis: promises, promises. Ann. N. Y. Acad. Sci. 694: 1-10.
27. MANDEL, I.D. 1993. A contemporary view of salivary research. Crit. Rev. Oral Biol. Med. 4: 599-604.
28. MANDEL, I.D. 1993. Salivary diagnosis: more than a lick and a promise. J. Am. Dent. Assoc. 124: 85-87.
29. BIOMARKERS DEFINITIONS WORKING GROUP. 2001. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69: 89-95.
30. FERGUSON, D.B. 1987. Current diagnostic uses of saliva. J. Dent. Res. 66: 420-424.
31. KAUFMAN, E. & I.B. LAMSTER. 2000. Analysis of saliva for periodontal diagnosis-a review. J. Clin. Periodontol. 27: 453-465.
32. NAKAMURA, M. & J. SLOTS. 1983. Salivary enzymes. Origin and relationship to periodontal disease. J. Periodontal Res. 18: 559-569.
33. OZMERIC, N. 2004. Advances in periodontal disease markers. Clin. Chim. Acta. 343: 1-16.
34. NAKASHIMA, K., C. GIANNOPOULOU, E. ANDERSEN, et al. 1996. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J. Clin. Periodontol. 23: 832-838.
35. SINGH, A.K., A.E. HERR, A.V. HATCH, et al. 2006. Integrated microfluidic platform for oral diagnostics (IMPOD) [abstract]. New York Academy of Sciences: Oral-Based Diagnostics - A New York Academy of Sciences Meeting.
36. RAMSEIER, C.A., J.S. KINNEY, A.E. HERR, et al. 2006. Salivary diagnostics for inflammatory periodontal diseases [abstract]. New York Academy of Sciences: Oral-Based Diagnostics - A New York Academy of Sciences Meeting.
37. KORNMAN, K.S., R.C. PAGE & M.S. TONETTI. 1997. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol. 2000. 14: 33-53.
38. MANTYLA, P., M. STENMAN, D.F. KINANE, et al. 2003. Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-side monitoring of periodontitis. J. Periodontal Res. 38: 436-439.
39. TABA, M., JR, J. KINNEY, A.S. KIM & W.V. GIANNOBILE. 2005. Diagnostic biomarkers for oral and periodontal diseases. Dent. Clin. North Am. 49: 551-571, vi.
40. CIMASONI, G. 1983. Crevicular fluid updated. Monogr. Oral Sci. 12: III-VII, 1-152.
41. LOOS, B.G. & S. TJOA. 2005. Host-derived diagnostic markers for periodontitis: do they exist in gingival crevice fluid? Periodontol 2000. 39: 53-72.
42. GOLUB, L.M., K. SIEGEL, N.S. RAMAMURTHY & I.D. MANDEL. 1976. Some characteristics of collagenase activity in gingival crevicular fluid and its relationship to gingival diseases in humans. J. Dent. Res. 55: 1049-1057.
43. GOLUB, L.M. & I. KLEINBERG. 1976. Gingival crevicular fluid: a new diagnostic aid in managing the periodontal patient. Oral Sci. Rev. 8: 49-61.
44. ROBERTSON, P.B., H.E. GRUPE, JR, R.E. TAYLOR, et al. 1973. The effect of collagenase-inhibitor complexes on collagenolytic activity of normal and inflamed gingival tissue. J. Oral Pathol. 2: 28-32.
45. KOWASHI, Y., F. JACCARD & G. CIMASONI. 1979. Increase of free collagenase and neutral protease activities in the gingival crevice during experimental gingivitis in man. Arch. Oral Biol. 24: 645-650.
46. VILLELA, B., R.B. COGEN, A.A. BARTOLUCCI & H. BIRKEDAL-HANSEN. 1987. Collagenolytic activity in crevicular fluid from patients with chronic adult periodontitis, localized juvenile periodontitis and gingivitis, and from healthy control subjects. J. Periodontal. Res. 22: 381-389.
47. AIRILA-MANSSON, S., B. SODER, K. KARI & J.H. MEURMAN. 2006. Influence of combinations of bacteria on the levels of prostaglandin E2, interleukin-1beta, and granulocyte elastase in gingival crevicular fluid and on the severity of periodontal disease. J. Periodontol. 77: 1025-1031.
48. IKARASHI, F., K. YAMAZAKI, K. HARA & H. NOHARA. 1990. Production of prostaglandin E2 by polymorphonuclear neutrophils isolated from gingival crevicular fluid and peripheral blood of dogs in periodontal health and disease. Nippon Shishubyo Gakkai Kaishi 32: 121-128.
49. WEYNA, E. 1985. Comparative evaluation of histological studies of the gingiva and levels of prostaglandin-like substances in cases of deep inflammatory periodontal disease. Czas. Stomatol. 38: 53-56.
50. WEYNA, E. 1983. Levels of prostaglandin-like substances in the gingiva of subjects with healthy periodontium or in patients with inflammatory periodontal disease as determined by biological methods. Czas. Stomatol. 36: 289-293.
51. LONING, T., H.K. ALBERS, B.P. LISBOA, et al. 1980. Prostaglandin E and the local immune response in chronic periodontal disease. Immunohistochemical and radioimmunological observations. J. Periodontal. Res. 15: 525-535.
52. GOODSON, J.M., F.E. DEWHIRST & A. BRUNETTI. 1974. Prostaglandin E2 levels and human periodontal disease. Prostaglandins 6: 81-85.
53. NAKASHIMA, K., N. ROEHRICH, G. CIMASONI. 1994. Osteocalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J. Clin. Periodontol. 21: 327-333.
54. OFFENBACHER, S., B.M. ODLE, R.C. GRAY & T.E. VAN DYKE. 1984. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J. Periodontal. Res. 19: 1-13.
55. OFFENBACHER, S., B.M. ODLE & T.E. VAN DYKE. 1986. The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J. Periodontal. Res. 21: 101-112.
56. PEDERSON, E.D., S.R. STANKE, S.J. WHITENER, et al. 1995. Salivary levels of alpha 2-macroglobulin, alpha 1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch. Oral Biol. 40: 1151-1155.
57. IIJIMA, K., K. ANDO, M. KISHI, et al. 1983. Collagenase activity in human saliva. J. Dent. Res. 62: 709-712.
58. BASU, M.K., E.C. FOX & J.F. BECKER. 1976. Salivary IgG and IgA before and after periodontal therapy. A preliminary report. J. Periodontal. Res. 11: 226-229.
59. SANDHOLM, L. & E. GRONBLAD. 1984. Salivary immunoglobulins in patients with juvenile periodontitis and their healthy siblings. J. Periodontol. 55: 9-12.
60. SANDHOLM, L., K. TOLO & I. OLSEN. 1987. Salivary IgG, a parameter of periodontal disease activity? High responders to Actinobacillus actinomycetemcomitans Y4 in juvenile and adult periodontitis. J. Clin. Periodontol. 14: 289-294.
61. SCHENCK, K., D. POPPELSDORF, C. DENIS & T. TOLLEFSEN. 1993. Levels of salivary IgA antibodies reactive with bacteria from dental plaque are associated with susceptibility to experimental gingivitis. J. Clin. Periodontol. 20: 411-417.
62. ISHIKAWA, I. & G. CIMASONI. 1970. Alkaline phosphatase in human gingival fluid and its relation to periodontitis. Arch. Oral Biol. 15: 1401-1404.
63. GIBERT, P., P. TRAMINI, V. SIESO & M.T. PIVA. 2003. Alkaline phosphatase isozyme activity in serum from patients with chronic periodontitis. J. Periodontal. Res. 38: 362-365.
64. TOTAN, A., M. GREABU, C. TOTAN & T. SPINU. 2006. Salivary aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase: possible markers in periodontal diseases? Clin. Chem. Lab. Med. 44: 612-615.
65. TODOROVIC, T., I. DOZIC, M. VICENTE- BARRERO, et al. 2006. Salivary enzymes and periodontal disease. Med. Oral Patol. Oral Cir. Bucal. 11: E115-E119.
66. MCCAULEY, L.K. & R.M. NOHUTCU. 2002. Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy. J. Periodontol. 73: 1377-1391.
67. KENNETT, C.N., S.W. COX & B.M. ELEY. 1997. Investigations into the cellular contribution to host tissue proteases and inhibitors in gingival crevicular fluid. J. Clin. Periodontol. 24: 424-431.
68. KUNIMATSU, K., K. YAMAMOTO, E. ICHIMARU, et al. 1990. Cathepsins B, H and L activities in gingival crevicular fluid from chronic adult periodontitis patients and experimental gingivitis subjects. J. Periodontal. Res. 25: 69-73.
69. ICHIMARU, E., M. TANOUE, M. TANI, et al. 1996. Cathepsin B in gingival crevicular fluid of adult periodontitis patients: identification by immunological and enzymological methods. Inflamm. Res. 45: 277-282.
70. CHEN, H.Y., S.W. COX & B.M. ELEY. 1998. Cathepsin B, alpha2-macroglobulin and cystatin levels in gingival crevicular fluid from chronic periodontitis patients. J. Clin. Periodontol. 25: 34-41.
71. COX, S.W. & B.M. ELEY. 1992. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid. A comparison of levels before and after basic periodontal treatment of chronic periodontitis patients. J. Clin. Periodontol. 19: 333-339.
72. ELEY, B.M. & S.W. COX. 1996. The relationship between gingival crevicular fluid cathepsin B activity and periodontal attachment loss in chronic periodontitis patients: a 2-year longitudinal study. J. Periodontal. Res. 31: 381-392.
73. WOESSNER, J.F., JR. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5: 2145-2154.
74. BIRKEDAL-HANSEN, H. 1993. Role of matrix metalloproteinases in human periodontal diseases. J. Periodontol. 64(5 Suppl): 474-484.
75. SALO, T., M. MAKELA, M. KYLMANIEMI, et al. 1994. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab. Invest. 70: 176-182.
76. LLANO, E., A.M. PENDAS, V. KNAUPER, et al. 1997. Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36: 15101-15108.
77. PIRILA, E., N. RAMAMURTHY, P. MAISI, et al. 2001. Wound healing in ovariectomized rats: effects of chemically modified tetracycline (CMT-8) and estrogen on matrix metalloproteinases -8, -13 and type I collagen expression. Curr. Med. Chem. 8: 281-294.
78. CHUBINSKAYA, S., K. HUCH, K. MIKECZ, et al. 1996. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab. Invest. 74: 232-240.
79. GOLUB, L.M., H.M. LEE, R.A. GREENWALD, et al. 1997. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm. Res. 46: 310-319.
80. LEE, W., S. AITKEN, G. KULKARNI, et al. 1991. Collagenase activity in recurrent periodontitis: relationship to disease progression and doxycycline therapy. J. Periodontal. Res. 26: 479-485.
81. LEE, W., S. AITKEN, J. SODEK & C.A. MCCULLOCH. 1995. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J. Periodontal. Res. 30: 23-33.
82. NOMURA, T., A. ISHII, Y. OISHI, et al. 1998. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases. Oral Dis. 4: 231-240.
83. MANCINI, S., R. ROMANELLI, C.A. LASCHINGER, et al. 1999. Assessment of a novel screening test for neutrophil collagenase activity in the diagnosis of periodontal diseases. J. Periodontol. 70: 1292-1302.
84. GOLUB, L.M., S. CIANCIO, N.S. RAMAMAMURTHY, et al. 1990. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J. Periodontal. Res. 25: 321-330.
85. GOLUB, L.M., M. WOLFF, S. ROBERTS, et al. 1994. Treating periodontal diseases by blocking tissue-destructive enzymes. J. Am. Dent. Assoc. 125: 163-169; discussion 169-171.
86. TERONEN, O., Y.T. KONTTINEN, C. LINDQVIST, et al. 1997. Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J. Dent. Res. 76: 1529-1537.
87. MA, J., U. KITTI, O. TERONEN, et al. 2000. Collagenases in different categories of peri-implant vertical bone loss. J. Dent. Res. 79: 1870-1873.
88. KIVELA-RAJAMAKI, M.J., O.P. TERONEN, P. MAISI, et al. 2003. Laminin-5 gamma2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid. Clin. Oral Implants. Res. 14: 158-165.
89. KIVELA-RAJAMAKI, M., P. MAISI, R. SRINIVAS, et al. 2003. Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. J. Periodontal. Res. 38: 583-590.
90. TENG, Y.T., J. SODEK & C.A. MCCULLOCH. 1992. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J. Periodontal. Res. 27: 544-552.
91. JOHANSSON, N. & V.M. KAHARI. 2000. Matrix metalloproteinases in squamous cell carcinoma. Histol. Histopathol. 15: 225-237.
92. KONTTINEN, Y.T., T. SALO, R. HANEMAAIJER, et al. 1999. Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate. Matrix Biol. 18: 401-412.
93. TERVAHARTIALA, T., E. PIRILA, A. CEPONIS, et al. 2000. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J. Dent. Res. 79: 1969-1977.
94. KIILI, M., S.W. COX, H.Y. CHEN, et al. 2002. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J. Clin. Periodontol. 29: 224-232.
95. UITTO, V.J., K. AIROLA, M. VAALAMO, et al. 1998. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am. J. Pathol. 152: 1489-1499.
96. FAGERHOL, M.K. 2000. Calprotectin, a faecal marker of organic gastrointestinal abnormality. Lancet. 356: 1783-1784.
97. POULLIS, A., R. FOSTER, M.A. MENDALL & M.K. FAGERHOL. 2003. Emerging role of calprotectin in gastroenterology. J. Gastroenterol. Hepatol. 18: 756-762.
98. KIDO, J., T. NAKAMURA, R. KIDO, et al. 1999. Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease. J. Clin. Periodontol. 26: 653-657.
99. NISAPAKULTORN, K., K.F. ROSS & M.C. HERZBERG. 2001. Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis. Infect. Immun. 69: 4242-4247.
100. BATAILLE, R., P. DELMAS & J. SANY. 1987. Serum bone gla-protein in multiple myeloma. Cancer 59: 329-334.
101. SLOVIK, D.M., C.M. GUNDBERG, R.M. NEER & J.B. LIAN. 1984. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J. Clin. Endocrinol. Metab. 59: 228-230.
102. GIANNOBILE, W.V., S.E. LYNCH, R.G. DENMARK, et al. 1995. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs. J. Clin. Periodontol. 22: 903-910.
103. KUNIMATSU, K., S. MATAKI, H. TANAKA, et al. 1993. A cross-sectional study on osteocalcin levels in gingival crevicular fluid from periodontal patients. J. Periodontol. 64: 865-869.
104. LEE, A.J., T.F. WALSH, S.J. HODGES, A. RAWLINSON. 1999. Gingival crevicular fluid osteocalcin in adult periodontitis. J. Clin. Periodontol. 26: 252-256.
105. WILLIAMS, R.C., D.W. PAQUETTE, S. OFFENBACHER, et al. 2001. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J. Periodontol. 72: 1535-1544.
106. GRIFFITHS, G.S., A.M. MOULSON, A. PETRIE & I.T. JAMES. 1998. Evaluation of osteocalcin and pyridinium crosslinks of bone collagen as markers of bone turnover in gingival crevicular fluid during different stages of orthodontic treatment. J. Clin. Periodontol. 25: 492-498.
107. GIANNOBILE, W.V., K.F. AL-SHAMMARI & D.P. SARMENT. 2003. Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontol. 2000 31: 125-134.
108. ARMITAGE, G.C., M.K. JEFFCOAT, D.E. CHADWICK, et al. 1994. Longitudinal evaluation of elastase as a marker for the progression of periodontitis. J. Periodontol. 65: 120-128.
109. ORINGER, R.J., M.D. PALYS, A. IRANMANESH, et al. 1998. C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin. Oral Implants. Res. 9: 365-373.
110. PALYS, M.D., A.D. HAFFAJEE, S.S. SOCRANSKY & W.V. GIANNOBILE. 1998. Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis. J. Clin. Periodontol. 25(11 Pt 1): 865-871.
111. SHIBUTANI, T., Y. MURAHASHI, E. TSUKADA, et al. 1997. Experimentally induced periodontitis in beagle dogs causes rapid increases in osteoclastic resorption of alveolar bone. J. Periodontol. 68: 385-391.
112. TALONPOIKA, J.T. & M.M. HAMALAINEN. 1994. Type I collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J. Clin. Periodontol. 21: 320-326.
113. GAPSKI, R., J.L. BARR, D.P. SARMENT, et al. 2004. Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial. J. Periodontol. 75: 441-452.
114. PEREZ, L.A., K.F. AL-SHAMMARI, W.V. GIANNOBILE & H.L. WANG. 2002. Treatment of periodontal disease in a patient with Ehlers-Danlos syndrome. A case report and literature review. J. Periodontol. 73: 564-570.
115. ORINGER, R.J., K.F. AL-SHAMMARI, W.A. ALDREDGE, et al. 2002. Effect of locally delivered minocycline microspheres on markers of bone resorption. J. Periodontol. 73: 835-842.
116. AL-SHAMMARI, K.F., W.V. GIANNOBILE, W.A. ALDREDGE, et al. 2001. Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels. J. Periodontol. 72: 1045-1051.
117. GIANNOBILE, W.V. 1999. C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction. Ann. N. Y. Acad. Sci. 878: 404-412.
118. TERMINE, J.D., H.K. KLEINMAN, S.W. WHITSON, et al. 1981. Osteonectin, a bonespecific protein linking mineral to collagen. Cell 26(1 Pt 1): 99-105.
119. BOWERS, M.R., L.W. FISHER, J.D. TERMINE & M.J. SOMERMAN. 1989. Connective tissue-associated proteins in crevicular fluid: potential markers for periodontal diseases. J. Periodontol. 60: 448-451.
120. OLDBERG, A., A. FRANZEN & D. HEINEGARD. 1986. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cellbinding sequence. Proc Natl. Acad. Sci. USA 83: 8819-8823.
121. RODAN, G.A. 1995. Osteopontin overview. Ann. N. Y. Acad. Sci. 760: 1-5.
122. REINHOLT, F.P., K. HULTENBY, A. OLDBERG & D. HEINEGARD. 1990. Osteopontin - a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA 87: 4473-4475.
123. KADONO, H., J. KIDO, M. KATAOKA, et al. 1999. Inhibition of osteoblastic cell differentiation by lipopolysaccharide extract from Porphyromonas gingivalis. Infect. Immun. 67: 2841-2846.
124. HEINEGARD, D., G. ANDERSSON, F.P. REINHOLT. 1995. Roles of osteopontin in bone remodeling. Ann. N. Y. Acad. Sci. 760: 213-222.
125. OWEN, T.A., M. ARONOW, V. SHALHOUB, et al. 1990. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell. Physiol. 143: 420-430.
126. IKEDA, T., S. NOMURA, A. YAMAGUCHI, et al. 1992. In situ hybridization of bone matrix proteins in undecalcified adult rat bone sections. J. Histochem. Cytochem. 40: 1079-1088.
127. HORTON, M.A., M.A. NESBIT & M.H. HELFRICH. 1995. Interaction of osteopontin with osteoclast integrins. Ann. N. Y. Acad. Sci. 760: 190-200.
128. KIDO, J., T. NAKAMURA, Y. ASAHARA, et al. 2001. Osteopontin in gingival crevicular fluid. J. Periodontal. Res. 36: 328-333.
129. SHARMA, C.G. & A.R. PRADEEP. 2006. Gingival crevicular fluid osteopontin levels in periodontal health and disease. J. Periodontol. 77: 1674-1680.